[1]
2026. A Systematic Review of Pharmacodynamics and Cardio-Renal Outcomes of SGLT-2 and DPP-4 Inhibition in Type 2 Diabetes Mellitus: Review Article. Journal of Pharma Insights and Research. 4, 1 (Feb. 2026), 013–022. DOI:https://doi.org/10.69613/45czct54.